KT

Krishna Tripuraneni

Director Director DIN 02396141
DIN 02396141 First appointment Aug 1995 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 1995
Shareholding value Locked Premium profile

About Krishna Tripuraneni

Data last updated:

Krishna Tripuraneni has 31 years in corporate governance. Formerly with 1 company, such as Kobo Biotech Limited. Engaged in Technology. Contributes to corporate operations.

DIN 02396141
Primary Designation Director
First Appointment 24 Aug 1995
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Kobo Biotech Limited L24110TG1993PLC016112
Director24 Aug 19951993Under Cirp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kobo Biotech Limited
Premium access

Shareholding and investment profile for Krishna Tripuraneni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishna Tripuraneni

Krishna Tripuraneni has 31 years in corporate governance. Formerly with 1 company, such as Kobo Biotech Limited. Engaged in Technology. Contributes to corporate operations.

Krishna Tripuraneni is associated with 0 companies as a director.

Krishna Tripuraneni has expertise in Technology.

Krishna Tripuraneni has 31 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available